Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma

Fig. 7

Evaluation of drug sensitivity between these two stemness subtypes in TCGA-LUSC dataset. A Differences between stemness subtype A and B groups in response to chemotherapy drugs including cisplatin, gemcitabine and vinorelbine. B The IC50 values of three EGFR-TKIs, erlotinib, gefitinib and afatinib between stemness subtype A and B groups. C The IC50 values of VEGFR, PARP1 and PI3K inhibitors between stemness subtype A and B groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us